消化性潰瘍治療市場：按產品類型、按適應症、按分銷渠道、按地區-規模、份額、展望、機會分析，2023-2030年

消化性潰瘍是在胃和小腸上部形成的開放性潰瘍。 消化性潰瘍最常見的症狀是胃痛。 消化性潰瘍包括：胃內部形成的胃潰瘍和小腸上部（十二指腸）內部形成的十二指腸潰瘍。 消化性潰瘍最常見的原因是幽門螺桿菌（H. pylori）感染和長期使用非甾體類抗炎藥（NSAID），如布洛芬（Advil、Motrin IB等）和□普生鈉（Aleb）壓力和辛辣食物不會引起消化性潰瘍。 然而，它會使症狀惡化。

消化性潰瘍最常見的症狀是胃灼痛。 胃酸會使疼痛加劇，空腹也會加劇疼痛。 消化性潰瘍是胃或小腸第一部分的開放性潰瘍。 大多數消化性潰瘍是在消化系統的保護膜受到細菌感染損害時發生的。 經常服用止痛藥的人更容易患潰瘍。

市場動態

監管機構產品批准的增加預計將在預測期內推動市場增長。 例如，2021年12月，製藥公司Edenbridge Pharmaceuticals宣布，美國食品藥品監督管理局已批准格隆溴銨口腔崩解片作為緩解和治療消化性潰瘍症狀的輔助藥物。

本研究的主要特點

• 本報告對全球消化性潰瘍藥物市場進行了深入分析，並預測了以 2022 年為基準年的預測期內（2023-2030 年）的市場規模和復合年增長率 (CAGR%)。 。
• 它揭示了各個細分市場的潛在收入機會，並描述了該市場有吸引力的投資主張矩陣。
• 它還提供了有關市場促進因素、抑制因素、機遇、新產品發布或批准、市場趨勢、區域前景以及主要參與者採取的競爭策略的重要見解。
• 它根據以下參數（公司亮點、產品組合、主要亮點、財務業績和戰略）介紹了全球消化性潰瘍治療市場的主要參與者。
• 本研究涵蓋的主要公司包括Daewoong Pharmaceutical Co., Ltd, Takeda Pharmaceutical Co., Ltd., Pfizer Inc., AstraZeneca plc., RedHill Biopharma, Cadila Healthcare Ltd., Novitium Pharma LLC., Boehringer Ingelheim GmbH, Eisai Co. Ltd., Yuhan Corporation, GlaxoSmithKline plc.。
• 從本報告中獲得的見解將使營銷人員和企業高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。 .
• 《全球消化性潰瘍治療市場報告》面向該行業的各個利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和財務分析師。
• 利益相關者可以通過用於分析全球消化性潰瘍藥物市場的各種策略矩陣來促進決策。

內容

第 1 章目的和先決條件

• 調查目的
• 先決條件
• 縮寫

第 2 章市場展望

• 報告概述
  • 市場定義和範圍
• 執行摘要
• 連貫的機會地圖 (COM)

第 3 章市場動態、監管與趨勢分析

• 市場動態
  • 促進因素
  • 抑制因素
  • 市場機會
• 影響分析
• 最近的產品公告
• 流行病學
• 合併、收購、聯合研究
• 監管場景
• 主要進展
• PEST分析
• 管道分析

第 4 章全球消化性潰瘍治療市場 - 冠狀病毒 (COVID-19) 大流行的影響

• 經濟影響
• COVID-19 的流行病學特徵
• 對供需的影響

第 5 章全球消化性潰瘍治療市場：按產品類型劃分，2017-2030

• 質子泵抑製劑
• 鉀競爭性酸阻滯劑 (P-CAB)
• 抗酸劑
• H2-拮抗劑
• 抗生素
• 潰瘍保護劑

第 6 章消化性潰瘍藥物的全球市場：疾病適應症，2017-2030

• 胃炎
• 胃潰瘍
• 十二指腸潰瘍
• 胃食管反流病 (GERD)

第 7 章消化性潰瘍藥物的全球市場：按分銷渠道劃分，2017-2030 年

• 醫院藥房
• 零售藥店
• 網上藥店

第 8 章消化性潰瘍藥物的全球市場：按地區劃分，2017-2030

• 北美
• 美國
• 加拿大
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 其他拉丁美洲地區
• 歐洲
• 英國
• 德國
• 意大利
• 法國
• 西班牙
• 俄羅斯
• 歐洲其他地區
• 亞太地區
• 中國
• 印度
• 日本
• 東盟
• 澳大利亞
• 韓國
• 亞太地區其他地區
• 中東
• 海灣合作委員會
• 以色列
• 其他中東地區
• 非洲
• 北非
• 中非
• 南非

第 9 章競爭格局

• Daewoong Pharmaceutical Co., Ltd.
• Takeda Pharmaceutical Co., Ltd.
• Pfizer Inc.
• AstraZeneca plc.
• RedHill Biopharma
• Cadila Healthcare Ltd.
• Novitium Pharma LLC.
• Boehringer Ingelheim GmbH
• Eisai Co. Ltd.
• Yuhan Corporation
• GlaxoSmithKline plc.

第 10 章

• 調查方法
• 關於出版商

Peptic ulcers are open sores that develop on the inside lining of your stomach and the upper portion of your small intestine. The most common symptom of a peptic ulcer is stomach pain. Peptic ulcers include: Gastric ulcers that occur on the inside of the stomach and Duodenal ulcers that occur on the inside of the upper portion of your small intestine (duodenum). The most common causes of peptic ulcers are infection with the bacterium Helicobacter pylori (H. pylori) and long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen (Advil, Motrin IB, others) and naproxen sodium (Aleve). Stress and spicy foods do not cause peptic ulcers. However, they can make your symptoms worse.

The most common peptic ulcer symptom is burning stomach pain. Stomach acid makes the pain worse, as does having an empty stomach. Peptic ulcer disease occurs when open sores, or ulcers, form in the stomach or first part of the small intestine. Many cases of peptic ulcer disease develop because a bacterial infection eats away the protective lining of the digestive system. People who frequently take pain relievers are more likely to develop ulcers.

Market Dynamics

An increase in product approval from the regulatory bodies is expected to drive the growth of the market over the forecast period. For instance, in December 2021, Edenbridge Pharmaceuticals, a pharmaceutical company, announced that the U.S. Food and Drug Administration have approved glycopyrrolate orally disintegrating tablets to reduce the symptoms of a peptic ulcer and as an adjunct to treatment of peptic ulcers.

Key features of the study:

• This report provides an in-depth analysis of the global peptic ulcer drugs market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global peptic ulcer drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Daewoong Pharmaceutical Co., Ltd, Takeda Pharmaceutical Co., Ltd., Pfizer Inc., AstraZeneca plc., RedHill Biopharma, Cadila Healthcare Ltd., Novitium Pharma LLC., Boehringer Ingelheim GmbH, Eisai Co. Ltd., Yuhan Corporation, GlaxoSmithKline plc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global peptic ulcer drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global peptic ulcer drugs market

Detailed Segmentation:

• Global Peptic Ulcer Drugs Market, By Product Type:
  • Proton Pump Inhibitors
  • Potassium-Competitive Acid Blocker (P-CAB)
  • Antacids
  • H2- Antagonist
  • Antibiotics
  • Ulcer Protective
• Global Peptic Ulcer Drugs Market, By Disease Indication:
  • Gastitis
  • Gastric Ulcer
  • Duodenal Ulcer
  • Gastroesophageal Reflux Disease (GERD)
• Global Peptic Ulcer Drugs Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• Global Peptic Ulcer Drugs Market, By Region:
  • North America
    • By Country:
  • U.S.
  • Canada
  • Latin America
    • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • By Country:
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • By Country/Region:
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
  • Daewoong Pharmaceutical Co., Ltd *
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Takeda Pharmaceutical Co., Ltd.
  • Pfizer Inc.
  • AstraZeneca plc.
  • RedHill Biopharma
  • Cadila Healthcare Ltd.
  • Novitium Pharma LLC.
  • Boehringer Ingelheim GmbH
  • Eisai Co. Ltd.
  • Yuhan Corporation
  • GlaxoSmithKline plc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product Type
  • Market Snapshot, By Disease Indication
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Recent Product Launches
• Epidemiology
• Merger, Acquisition, and Collaborations
• Regulatory Scenario
• Key Developments
• PEST Analysis
• Pipeline Analysis

4. Global Peptic Ulcer Drugs Market- Impact of Coronavirus (Covid-19) Pandemic

• Economic Impact
• COVID-19 Epidemiology
• Impact on Supply and Demand

5. Global Peptic Ulcer Drugs Market, By Product Type, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Proton Pump Inhibitors
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Potassium-Competitive Acid Blocker (P-CAB)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Antacids
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• H2- Antagonists
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Antibiotics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Ulcer Protective
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Peptic Ulcer Drugs Market, By Disease Indication, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Gastitis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Gastric Ulcer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Duodenal Ulcer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Gastroesophageal Reflux Disease (GERD)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Peptic Ulcer Drugs Market, By Distribution Channel, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Peptic Ulcer Drugs Market, By Region, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, By Region, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, For Regions, 2018-2030
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
• North Africa
• Central Africa
• South Africa

9. Competitive Landscape

• Daewoong Pharmaceutical Co., Ltd.*
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Takeda Pharmaceutical Co., Ltd.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
• Pfizer Inc.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
• AstraZeneca plc.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
• RedHill Biopharma
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
• Cadila Healthcare Ltd.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
• Novitium Pharma LLC.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
• Boehringer Ingelheim GmbH
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
• Eisai Co. Ltd.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
• Yuhan Corporation
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
• GlaxoSmithKline plc.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies

10. Section

• Research Methodology
• About Us